Viewing Study NCT02262858


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-01-03 @ 6:00 AM
Study NCT ID: NCT02262858
Status: COMPLETED
Last Update Posted: 2014-10-13
First Post: 2014-10-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module